Stockreport

Fennec Pharmaceuticals Expands Possible TAM Significantly [Seeking Alpha]

Fennec Pharmaceuticals Inc.  (FENC) 
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.fennecpharma.com/investor-relations
PDF The company faced challenges and delays in obtaining FDA approval but finally launched PEDMARK® in late 2022, and generated $6.5 million in sales in Q3 2023. The comp [Read more]